Announced
Completed
Financials
Tags
Single Bidder
Majority
Friendly
Private Equity
United States
Biotechnology
Domestic
Completed
oncology company
Acquisition
Venture Capital
Private
Synopsis
RA Capital Management and Nextech Invest led a $105m Series B round in Boundless Bio, a next-generation precision oncology company, with participation from Fidelity Management & Research Company, Redmile Group, Wellington Management, Surveyor Capital, PFM Health Sciences, Logos Capital, ARCH Venture Partners, City Hill Ventures, Vertex Ventures HC, GT Healthcare Capital Partners, Boxer Capital and Alexandria Venture Investments. "RA Capital has been following the Boundless Bio story for some time now and believes that the team has developed industry-leading expertise in the biology that underlies high unmet need, gene amplified tumors," Zach Scheiner, RA Capital Management Principal.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.